Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 12:13 pm Purchase | 2023-12-31 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Montanova Capital, LLC | 5,463,641 9.990% | 491,981 (+9.90%) | Filing History |
| 2024-02-13 12:08 pm Purchase | 2023-12-31 | 13G | FULCRUM THERAPEUTICS INC FULC | Montanova Capital, LLC | 5,518,881 8.900% | 1,244,078 (+29.10%) | Filing History |
| 2024-02-13 12:00 pm Purchase | 2023-12-31 | 13G | EYEPOINT INC EYPT | Montanova Capital, LLC | 4,774,389 9.990% | 1,363,179 (+39.96%) | Filing History |
| 2024-02-13 11:55 am Purchase | 2023-12-31 | 13G | KEZAR LIFE SCIENCES INC KZR | Montanova Capital, LLC | 716,759 9.900% | 366,333 (+104.54%) | Filing History |
| 2024-02-13 11:50 am Purchase | 2023-12-31 | 13G | ARCELLX INC ACLX | Montanova Capital, LLC | 2,435,974 5.000% | 85,641 (+3.64%) | Filing History |
| 2024-02-13 11:44 am Purchase | 2023-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | Montanova Capital, LLC | 5,837,126 9.500% | 2,388,851 (+69.28%) | Filing History |
| 2024-02-05 4:43 pm Purchase | 2024-01-26 | 13G | COGENT BIOSCIENCES INC COGT | Montanova Capital, LLC | 5,481,034 6.400% | 5,481,034 (New Position) | Filing History |
| 2023-10-30 5:03 pm Purchase | 2023-10-20 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Montanova Capital, LLC | 9,592,212 9.990% | 9,592,212 (New Position) | Filing History |
| 2023-10-30 5:02 pm Purchase | 2023-10-18 | 13G | 89BIO INC ETNB | Montanova Capital, LLC | 4,808,374 6.400% | 4,808,374 (New Position) | Filing History |
| 2023-06-15 4:31 pm Purchase | 2023-06-05 | 13G | ZURA BIO LTD ZURA | Montanova Capital, LLC | 2,850,000 6.600% | 2,850,000 (New Position) | Filing History |
| 2023-04-24 4:47 pm Purchase | 2023-04-12 | 13G | INFLARX N V COM IFRX | Montanova Capital, LLC | 5,733,910 10.300% | 3,587,670 (+167.16%) | Filing History |
| 2023-04-18 4:16 pm Sale | 2022-12-31 | 13G | BENITEC BIOPHARMA INC BNTC | Montanova Capital, LLC | 177,660 9.990% | -194,616 (-52.28%) | Filing History |
| 2023-03-10 5:15 pm Purchase | 2023-01-25 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Montanova Capital, LLC | 1,796,379 5.300% | 724,077 (+67.53%) | Filing History |
| 2023-02-13 4:37 pm Purchase | 2022-12-31 | 13G | PROKIDNEY CORP PROK | Montanova Capital, LLC | 6,280,175 10.200% | 10,875 (+0.17%) | Filing History |
| 2023-02-13 1:44 pm Sale | 2022-12-31 | 13G | DISC MEDICINE INC IRON | Montanova Capital, LLC | 0 0.000% | -237,227 (Position Closed) | Filing History |
| 2023-02-13 1:31 pm Purchase | 2022-12-31 | 13G | BIOHAVEN RESH LTD. USD COM SHS BHVN | Montanova Capital, LLC | 3,848,938 5.700% | 8,600 (+0.22%) | Filing History |
| 2023-02-13 1:21 pm Sale | 2022-12-31 | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Montanova Capital, LLC | 36,822,190 5.900% | -8,888,145 (-19.44%) | Filing History |
| 2023-02-13 1:07 pm Purchase | 2022-12-31 | 13G | KURA ONCOLOGY INC KURA | Montanova Capital, LLC | 6,376,815 9.300% | 2,804,396 (+78.50%) | Filing History |
| 2023-02-13 12:36 pm Sale | 2022-12-31 | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | Montanova Capital, LLC | 0 0.000% | -111,513 (Position Closed) | Filing History |
| 2023-02-13 12:25 pm Purchase | 2022-12-31 | 13G | BENITEC BIOPHARMA INC BNTC | Montanova Capital, LLC | 372,276 9.990% | 327,041 (+722.98%) | Filing History |